Search results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 23 hours agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
FDA approves first RSV vaccine for use in at-risk adults over 50
The Hill via AOL· 5 days agoThe Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 3 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
FDA clears GSK's RSV vaccine for adults ages 50-59
United Press International via Yahoo News· 5 days agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 6 days agoThe shot, called Arexvy, is the first vaccine cleared by the FDA to protect that population from...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance· 3 days agoArexvy had an exceptional launch and generated...GSK expects Arexvy to generate more than £3 billion...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 22 hours agoThe vaccine, dubbed...older adults it can be serious or even deadly. Moderna will rival Pfizer and...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 6 days agoThe vaccine is based on protein technology, differentiating it from Pfizer's and Moderna's messenger...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 23 hours agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...
FDA Gives Nod to RSV Vaccine for People in Their 50s | FOX 28 Spokane
FOX 28 Spokane· 3 days agoDrugmaker GSK’s Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved...